Gilead Sciences

NASDAQ: GILD
$66.94
-$0.04 (-0.1%)
Closing price January 22, 2021

Top Analyst Upgrades and Downgrades: Airbnb, Amex, Arch Capital, Carlyle, Darden, Facebook, Eli Lilly, Nio and More
Tuesday's top analyst upgrades and downgrades included Airbnb, American Express, Arch Capital, Carlyle, Darden Restaurants, Facebook, Eli Lilly and Nio.
Lee Jackson
3 days ago
Last Updated: 3 days ago

Why Lululemon Raised Earnings Guidance to High End of Range
As earnings season begins, Lululemon Athletica and other companies are updating guidance for the quarter just ended and for the 2020 fiscal year.
Paul Ausick
11 days ago

Citigroup, Gilead, Groupon, Morgan Stanley, Spotify and More Monday Afternoon Analyst Calls
Although the markets may be falling, 24/7 Wall St. is taking a look at some big analyst calls that we have seen so far on Monday.
Chris Lange
18 days ago
Last Updated: 18 days ago

Top Analyst Upgrades and Downgrades: AT&T, Boeing, Conoco, Gilead, Illumina, Lam Research, Raytheon, Yum Brands and More
Thursday's top analyst upgrades and downgrades included AT&T, Boeing, ConocoPhillips, Gilead Sciences, Illumina, Lam Research, Raytheon Technologies and Yum Brands.
Lee Jackson
1 month ago
Last Updated: 1 month ago

Why Gilead Retreated on Rheumatoid Arthritis Treatment
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
Chris Lange
1 month ago

Which Big Biotechs Short Sellers Favor Now
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
1 month ago

Big Biotech Short Sellers Seek Cover
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
1 month ago

With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Chris Lange
1 month ago

Top Analyst Upgrades and Downgrades: Amgen, Boeing, eBay, Etsy, Fastly, Fiverr, Ford, GE, Gilead, Pinterest, Six Flags and More
Thursday's top analyst upgrades and downgrades included Amgen, Boeing, eBay, Etsy, Fastly, Fiverr, Ford, General Electric, Gilead Sciences, Pinterest and Six Flags.
Jon C. Ogg
2 months ago
Last Updated: 2 months ago

These Two Major Biotechs Are Bouncing Back With Q3 Results
Amgen and Gilead released their most recent financial results after the closing bell on Wednesday.
Chris Lange
2 months ago

Major Biotechs Have Short Sellers Looking Both Ways
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
2 months ago

Gilead Is the First COVID-19 Stock to Win FDA Approval
Gilead Sciences is the first company to cross the finish line for regulatory approval in the fight against the coronavirus.
Chris Lange
2 months ago

6 Unpopular Stocks That Scored Major Analyst Upgrades Ahead of Earnings
Some battered stocks that have not risen back to their highs are attracting some interesting analyst upgrades and new coverage.
Jon C. Ogg
3 months ago

Short Sellers Need to Find a Clue on Major Biotechs
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
3 months ago

4 Very Profitable Biotech Stocks Expected to Soar Into 2021
24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive strategies is biotech and pharmaceuticals.
Jon C. Ogg
3 months ago